|Day Low/High||114.28 / 117.76|
|52 Wk Low/High||47.78 / 121.98|
Company's total lab processing capacity expected to reach 7 million by end of year
A roundup of Jim Cramer's thoughts on stocks of interest to Mad Money viewers.
By going after friendly trading partners and big tech Trump is forcing Wall Street to re-calibrate and lower valuations, Jim Cramer says.
MADISON, Wis., May 31, 2019 /PRNewswire/ -- Exact Sciences Corp.
Early data on pancreatic cancer detection presented at Digestive Disease Week® 2019
Researchers to Present Real-World Findings at Digestive Disease Week® 2019
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in EXACT Sciences Corp. , where a total volume of 10,929 contracts has been traded thus far today, a contract volume which is representative of approximately 1.1 million underlying shares (given that every 1 contract represents 100 underlying shares).
MADISON, Wis., May 1, 2019 /PRNewswire/ -- Exact Sciences Corp.
- Estimated Cologuard market share increased to 4.6 percent during the first quarter
Former Health and Human Services Secretary brings government and health care expertise to company working to detect cancer earlier
Shares of Exact Sciences has been on the upswing, but the stock price of the cancer screening test firm may be vulnerable.
Jim Cramer's watching six stocks to determine when the selling will end.
MADISON, Wis., March 5, 2019 /PRNewswire/ -- Exact Sciences Corporation (NASDAQ: EXAS) (the "Company") today announced an underwritten public offering of $600 million aggregate principal amount of convertible senior notes due 2027 (the "Notes") pursuant...
MADISON, Wis., March 1, 2019 /PRNewswire/ -- Exact Sciences Corp.
Exact Sciences Announces Milestone Ahead of Cologuard Classic, National Colorectal Cancer Awareness Month
- Fourth quarter revenue increased 64 percent to $143.0 million
Jim Cramer's plan for getting through the heart of earnings season next week.
Jim Cramer weighs in on Cronos, Fortinet, Dominion Energy and more.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AES, ALIM, APPS, EXAS, INVH, LBRDA, LBRDK, LLY, TLK Downgrades: CTT, DRH, HA, MTDR, ORIT, RNG Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Our strategy on EXAS shares after the company's latest earnings.
Jim Cramer takes a closer look at Costco, Tellurian, Exact Sciences, XPO Logistics, Align Technology and more.
Jim Cramer says investors need to remember how terrific these companies are, and why they can't be written off.
Jim Cramer takes a closer look at Raytheon, Northrop Grumman, Zuora, Exact Sciences.
This trillion-dollar level is so meaningful, Jim Cramer says, because Apple may be the first company to get here, but it won't be the last. Get ready.
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component EXACT Sciences Corp. was identified as having a larger market cap than the smaller end of the S&P 500, for example Qorvo Inc , according to The Online Investor.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.